Blockchain Registration Transaction Record

NRx Pharmaceuticals CEO to Deliver Company Update at Wall Street Conference in May 2025

NRx Pharmaceuticals CEO Dr. Jonathan Javitt to present company update at Wall Street Conference in May 2025. Learn about NRX-100 progress and strategic acquisition plans for treating central nervous system disorders.

NRx Pharmaceuticals CEO to Deliver Company Update at Wall Street Conference in May 2025

This news highlights NRx Pharmaceuticals' advancements in developing treatments for central nervous system disorders, including suicidal bipolar depression and chronic pain. The company's presentation at the conference signifies a significant step in its efforts to bring innovative therapies to market.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x5b78934eeaef9902cf05feb4b8f770d223fb0429c272a1808541b0311ecfae74
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintopenWrDf-fd0291b98eba401f6e3c6510897329d3